The GOP-led House Judiciary Committee is requesting records from Pfizer’s CEO and an interview with a former company ...

U.S. lawmakers on Thursday asked Pfizer Inc for information on alleged comments by a former executive suggesting its research ...

For years, U.S. vaccine experts have issued a universal recommendation for Covid vaccines. That could change soon.

Pfizer (PFE) stock draws public scrutiny as a House probe gathers new allegations regarding the company's COVID-19 vaccine ...

Researchers aim to develop a universal vaccine platform that could protect against both COVID-19 and influenza without annual ...

A new vaccine developed by Moderna aims to protect against both flu and COVID-19 with just one shot. Early studies suggest ...

Streptococcus Group A affects close to 20% of U.S. children, according to Dr. Joshua Osowicki, senior research fellow at the ...

A decades-long scientific challenge in HIV vaccine development has been finding a way to train the immune system to produce antibodies that can target many variants of the virus.

Novavax posts $667 million in Q1 2025 revenue and $2.93 EPS, boosted by Sanofi payments and APA terminations; full-year ...

Novavax on Thursday tried to calm investors spooked by the delay of full approval of its COVID vaccine shot by U.S.

Francis Collins, who served as director until 2021, wasn’t shy about pushing through the NIH’s neuroscience-focused BRAIN ...